Valuation: CeriBell, Inc.

Market Cap 909M 808M 754M 687M 1.3B 87.4B 1.31B 9.12B 3.54B 44.68B 3.41B 3.34B 143B P/E 2026 *
-12x
P/E 2027 * -14.7x
Enterprise Value 914M 812M 758M 691M 1.3B 87.87B 1.32B 9.17B 3.55B 44.92B 3.43B 3.36B 144B EV / Sales 2026 *
7.92x
EV / Sales 2027 * 6.38x
Free-Float
88.16%
Yield 2026 *
-
Yield 2027 * -
1 day+0.34%
Current month-2.87%
1 month-3.58%
3 months+21.18%
6 months+27.57%
Current year+8.03%
1 week 23.32
Extreme 23.315
25.25
1 month 23.04
Extreme 23.04
25.63
Current year 15.84
Extreme 15.84
25.63
1 year 10.85
Extreme 10.85
25.63
3 years 10.01
Extreme 10.01
32.75
5 years 10.01
Extreme 10.01
32.75
10 years 10.01
Extreme 10.01
32.75
Manager TitleAgeSince
Chief Executive Officer 46 30/09/2015
Director of Finance/CFO 44 31/03/2020
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Director/Board Member 46 28/08/2014
Chairman 57 28/08/2014
Director/Board Member 64 31/03/2021
Date Insider Type Main position Quantity % Market Cap. Importance
15/09/26 Exercice

Chief Financial Officer

2,538 0.0066%
15/09/26 Sell

Founder

-20,846 0.0543%
08/09/26 Sell

Executive/Senior Manager

-24,255 0.0632%
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%0.00%+87.42% - 909M
+0.35%-2.99%+20.52%+31.06% 242B
+1.09%-4.65%-0.43%-0.76% 150B
-2.32%-3.27%-13.35%+36.07% 138B
-1.46%-3.01%-56.23%-17.35% 61.74B
-0.05%-1.32%+10.48%+22.34% 49.08B
+0.66%+0.19%-20.53%-20.70% 47.43B
+0.66%-2.90%+18.46%+52.17% 47.3B
-3.05%-2.62%-7.75%+36.49% 44.25B
-0.08%-1.92%+29.48%+60.45% 41.78B
Average -0.39%-2.25%+6.81%+22.20% 82.35B
Weighted average by Cap. -0.29%-3.27%+1.17%+21.95%

Financials

2026 *2027 *
Net sales 115M 103M 95.76M 87.28M 165M 11.1B 166M 1.16B 449M 5.68B 434M 424M 18.21B 147M 131M 122M 111M 210M 14.14B 212M 1.48B 572M 7.23B 552M 540M 23.2B
Net income -75.94M -67.47M -62.98M -57.4M -108M -7.3B -109M -762M -295M -3.73B -285M -279M -11.98B -64M -56.86M -53.07M -48.37M -91.23M -6.15B -92.08M -642M -249M -3.15B -240M -235M -10.09B
Net Debt 4.85M 4.31M 4.02M 3.66M 6.91M 466M 6.97M 48.64M 18.85M 238M 18.2M 17.8M 764M 29.76M 26.44M 24.68M 22.49M 42.42M 2.86B 42.82M 299M 116M 1.46B 112M 109M 4.69B
Logo CeriBell, Inc.
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its hardware is composed of disposable, flexible headbands and head caps (Wearables) and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals. EEG data captured by the recorder are interpreted by its proprietary AI-powered seizure detection algorithms, which monitor the patient’s EEG signal and support the clinician’s real-time assessment of seizure activity.
Employees
327
Date Price Change Volume
02/10/26 US$23.69 +0.34% 307,031
01/10/26 US$23.61 -3.20% 316,704
30/09/26 US$24.39 -1.89% 336,291
29/09/26 US$24.86 +1.43% 300,860
28/09/26 US$24.51 +3.46% 217,929
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
23.69USD
Average target price
28.57USD
Spread / Average Target
+20.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CBLL Stock